Serial 88063005
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Oct 2025)
What this means for you
Registered since 19 May 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 May 2030: the §8 & §9 renewal).
Record
- Serial number
- 88063005
- Registration number
- 6059422
- Mark type
- Design / logo
- Filed
- 02 Aug 2018
- Published for opposition
- 25 Dec 2018
- Registered
- 19 May 2020
- Next maintenance filing
- §8 & §9 renewal, due by 19 May 2030 (grace period to 19 Nov 2030)
- Attorney of record
- Douglas A. Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological disorders
Owner
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
Prosecution history
- 10 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 19 May 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 May 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Apr 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Apr 2020 — USE AMENDMENT FILED
- 08 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 26 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Mar 2020 — SOU EXTENSION 2 GRANTED
- 19 Feb 2020 — SOU EXTENSION 2 FILED
- 25 Mar 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL